Exozymes Inc (EXOZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||
| Net Income | -5,861 | -2,038 |
| Depreciation Amortization | 213 | 145 |
| Accounts receivable | 145 | -73 |
| Accounts payable and accrued liabilities | -4,243 | 205 |
| Other Working Capital | -4,018 | 220 |
| Other Operating Activity | 5,259 | 360 |
| Operating Cash Flow | $-8,506 | $-1,181 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -397 | -289 |
| Other Investing Activity | 37 | -23 |
| Investing Cash Flow | $-359 | $-311 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 3,977 | 1,000 |
| Common Stock Issued | 14,541 | N/A |
| Financing Cash Flow | $18,518 | $1,000 |
| Beginning Cash Position | 67 | 559 |
| End Cash Position | 9,719 | 67 |
| Net Cash Flow | $9,653 | $-492 |
| Free Cash Flow | ||
| Operating Cash Flow | -8,506 | -1,181 |
| Capital Expenditure | -397 | -289 |
| Free Cash Flow | -8,902 | -1,470 |